Brachial Plexus Block Group 1 for Postoperative Pain
This trial looks at a new way to do nerve block procedures, considering both the success and side effects of the block.
- Postoperative Pain
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the current regulatory status of Brachial Plexus Block Group 1?
"Given the Phase 4 trial status, our experts at Power assigned Brachial Plexus Block Group 1 a rating of 3 to reflect its established safety profile."
Is there availability for participation in this experiment?
"As evidenced by the information on clinicaltrials.gov, this research study is actively seeking qualified participants. The original posting was made on February 17th 2023 and most recently updated on May 11th 2023."
What is the cohort size for this experimental protocol?
"Affirmative. According to the available information on clinicaltrials.gov, this research is currently recruiting participants with an initial posting date of February 17th 2023 and a most recent edit on May 11th 2023. The study requires 150 people from 1 medical site."
What end-results is this research attempting to realize?
"This 60-minute study looks to assess Lung Function, as well as gauge Vital Capacity (in L), Pulse Oximetry changes, and the rate of Dyspnea/Horner's/Hoarseness side effects."